The cost of these medications can increase with higher dosages, combination therapy with other diabetes medications, and long-acting formulations that are administered less frequently
Approval for Sleep Apnea, MASH, CKD Tirzepatide (Zepbound) originally approved for weight loss now also holds FDA approval for the treatment of moderate to severe obstructive sleep apnea in adults with obesity
GLP-1RAs show promise in regulating the intestinal nervous system, immune system, and endocrine pathways, offering therapeutic potential for conditions such as IBS [55,56,57, 59]
View third-party Certificates of Analysis (COAs) on our Lab Results page
Geographic and Jurisdiction Notice: Per HumeCare's Terms of Service, the Services are available only in the United States, in states where HumeCare's Clinical Network maintains licensed physician coverage, and are not currently available in Alabama, Arkansas, Louisiana, or Mississippi